VAERS Reports 024M20A /017B21

VAERS 1788392

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 024M20A, 017B21

moderat

Staat: MI
Alter: 87,0
Geschlecht: F
Eingang: 15.10.2021
Impfdatum: 05.04.2021
Beginn: 12.10.2021
Tage bis Beginn: 190,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 Condition aggravated Decreased appetite Dyspnoea Impaired self-care SARS-CoV-2 test positive

Symptomtext

Generalized weakness, SOB, decreased ability to care for self, decreased appetite.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: COVID positive
Aktuelle Erkrankungen: Unknown
Vorgeschichte: COPD, lung cancer, weakness, SOB, decreased appetite.
Andere Medikamente: Unknown
Allergien: Sulfa drugs, Seafood
Vorherige Impfungen: -

VAERS 1609822

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 024M20A /017B21

mild

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 22.08.2021
Impfdatum: 25.03.2021
Beginn: 25.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Hyperhidrosis Lethargy Myalgia Pain of skin Pyrexia

Symptomtext

This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), LETHARGY (Lethargic), MYALGIA (Body ache), FATIGUE (Fatigue) and HEADACHE (Headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A /017B21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included PREDNISONE, DEXAMETHASONE ACETATE (DECADRON A), METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]), CYANOCOBALAMIN, FOLIC ACID, IRON PENTACARBONYL, ZINC (ZENFER Z) and CIPROFLOXACIN HYDROCHLORIDE (CIPRO [CIPROFLOXACIN HYDROCHLORIDE]) for an unknown indication. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), LETHARGY (Lethargic), MYALGIA (Body ache), FATIGUE (Fatigue), HEADACHE (Headache), PAIN OF SKIN (Skin pain) and PYREXIA (Low grade fever). At the time of the report, HYPERHIDROSIS (Sweating), LETHARGY (Lethargic), FATIGUE (Fatigue), HEADACHE (Headache), PAIN OF SKIN (Skin pain) and PYREXIA (Low grade fever) outcome was unknown. Not Provided mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Treatment medication include Prednisone, Decadron, Medrol, Zenefrax and Cipro. Concomitant product use was not provided. This case was linked to MOD-2021-082902 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: PREDNISONE; DECADRON A; MEDROL [METHYLPREDNISOLONE]; ZENFER Z; CIPRO [CIPROFLOXACIN HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -